Economic reports in the week ahead
The week ahead will mark the beginning of the Q1 earnings season, with big banks such as JPMorgan Chase (JMP), Goldman Sachs (NYSE:GS) and Wells Fargo (NYSE:WFC) heading into the earnings confessional. The airline sector will also be watched closely, with Delta Air Lines (NYSE:DAL) due to report earnings and update on Q2-Q3 booking trends. Federal Reserve speakers will also make the circuit as investors continue to eye the pace of rate hikes, while the economic calendar is headlined by the highly anticipated Consumer Price Index report on April 12. The CPI is expected to show inflation rising 1.1% in March on a month-to-month comparison and 8.4% from a year ago. That’s an acceleration from the pace seen in February. Updates on producer prices, retail sales and consumer sentiment are also due in next week. In the tech sector, a question-and-answer session next week at Twitter (NYSE:TWTR) with employees and new board director Elon Musk could create some jolts.
Earnings spotlight: Tuesday, April 12 Albertsons (ACI) and CarMax (KMX).
Earnings spotlight: Wednesday, April 13 Bed, Bath & Beyond (BBBY), BlackRock (BLK), Delta Air Lines (DAL) and JPMorgan (NYSE:JPM).
Earnings spotlight: Thursday, April 14 Ally Financial (ALLY), Citigroup (C), Goldman Sachs (GS), Rite Aid (RAD), Morgan Stanley (MS), PNC Financial (PNC) and Wells Fargo (WFC).
IPO watch: Excelerate Energy (EE) is expected to start trading next week. Meanwhile, the quiet period ends on April 11 for Akanda (AKAN), which will free up analysts to post ratings. Investors should also keep an eye on IPO lockup expirations hitting during the week on Healthcare Triangle (HCTI), Gitlab (GTLB), IHS Holding (IHS), Lucid Diagnostics (LUCD) and MiNK (INKT). All those stocks are currently trading below their IPO price levels.
AACR meeting: The annual meeting of the American Association for Cancer Research will continue to run, with trial data expected out from a large number of companies, including Vaccinex (VCNX), Bicyle Therapeutics (BCYC), Repare Therapeutics (RPTX), AIM ImmunoTech (AIM and LLY. Bank of America singled out C4 Therapeutics (CCCC) as a potential share price mover off the data release, while Wells Fargo identified Affimed (AFMD), Gracell Biotechnologies (GRCL) and IMV Inc. (IMV) as the companies with key updates.
Corporate events: Ambev (ABEV) will hold a Investor Day event from Sao Paulo, Brazil, on April 11-12. Enerplus Corp. (ERF) will hold a webcast for investors on the Bakken on April 12, and T2 Biosystems (TTOO) will host an Analyst and Investor Day event that is set to focus on the company’s commercial strategy and product pipeline. On April 13, PVH Corp. (NYSE:PVH) will host an Investor Day event to provide an overview of the company’s multi-year strategic growth plan, and Ford (F) Chief Financial Officer John Lawler will participate in a fireside chat at Bank of America’s Global Automotive Summit. Also watch for Tesla (TSLA) CEO Elon Musk’s TED talk, which should attract a lot of attention following the large stake he recently took in Twitter (TWTR). The week is capped off with Ooma (NYSE:OOMA) hosting a virtual Investor Day on April 14.
Conference schedule: The Jefferies Virtual Space Summit will include appearances from upstarts like Redwire Corporation (RDW), Spire Global (SPIR) and BlackSky Technology (BKSY). The conference schedule also includes the Needham Healthcare Conference, the Wells Fargo Biotech Forum, the Cantor U.S. Cannabis Conference and the Canaccord Genuity Horizons in Oncology Virtual Conference. Here’s a more detailed list of events that may impact share prices next week.
Tesla watching: Tesla (TSLA) will be in the spotlight once again next week, with investors sizing up the significance of the ramp-up of production that will follow the opening of the gigafactories in Berlin and Austin. Wedbush Securities forecasts Tesla (TSLA) could exit the year with an annual production run rate of 2 million vehicles, although the zero-tolerance COVID policy in Shanghai is a significant wildcard. Tesla’s scale advantage with production and EV tech is seen potentially creating separation with EV upstarts like Fisker (FSR), Lucid Group (LCID) and Rivian Automotive (RIVN) if the market turns further toward risk-off trading.
Large-cap banks earnings preview: U.S. bank heavyweights will report earnings next week amid expectations that profit will fall sharply from the level recorded a year ago, when deal-making was revving higher. Net income for the six biggest U.S. banks is forecast to be down about 35% from last year, with a sharp deceleration in activity seen during March following the Russian invasion of Ukraine. Bank reports will be watched closely on the costs side, particularly with labor, technology and acquisition expenses rising. UBS thinks there could be a surprise to the upside for the sector with guidance likely to highlight that the benefits of higher rates and better-than-anticipated loan growth could offset higher credit cost provisions and weaker equity markets. The firm recommends Bank of America (NYSE:BAC) amid the rising rate environment, while warning that Wells Fargo (WFC) could underperform peers.
Annual meetings: Adobe Inc. (NASDAQ:ADBE) is scheduled to hold its annual meeting on April 14.
Barron’s mentions: The cover story delves into the rise of retail crime on the impact for national chains like Target (TGT), Walgreens (WBA), Best Buy (BBY) and Kroger (KR). The issue has become progressively worse since 2015 when the National Retail Federation estimated that retailers lost more than $450,000 to theft for every $1 billion in sales. The relevance for investors is that the loss to theft is now estimated to be as high as $700,000 per $1 billion in sales. In the airline sector, Delta Air Lines (DAL) is called out as a top pick. Delta’s ownership of a high-margin oil refinery is said to make it stand out from peers. In a look across the Atlantic, Europe’s efforts to reduce reliance on Russian fossil fuels are seen making Shell (SHEL) and TotalEnergies (TTE) attractive picks to ride out the war volatility.
Be the first to comment